PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

Sancak, Yasemin, Thoreen, Carson C., Peterson, Timothy R., Lindquist, Robert A., Kang, Seong A., Spooner, Eric, Carr, Steven A., Sabatini, David M.·2007·Molecular Cell
DOI 10.1016/j.molcel.2007.03.003

Cited by (1,000)

Items 801–900 of 1,000

  1. Mechanistic / mammalian target protein of rapamycin signaling in hematopoietic stem cells and leukemia
    Atsushi Hirao, Takayuki Hoshii · 2013 · Cancer Science
  2. Mechanisms and implications of podocyte autophagy in chronic kidney disease
    Rachel Njeim, Sandra Merscher, Alessia Fornoni · 2024 · American Journal of Physiology-Renal Physiology
  3. The Cytoprotective and Cytotoxic Functions of Autophagy in Response to mTOR Inhibitors
    Ahmed M. Elshazly, Aya A. Elzahed, David A. Gewirtz · 2024 · Frontiers in Bioscience-Landmark
  4. Unveiling the Role of Mechanistic Target of Rapamycin Kinase (MTOR) Signaling in Cancer Progression and the Emergence of MTOR Inhibitors as Therapeutic Strategies
    Devashish Mehta, Kajal Rajput, Dolly Jain, Avinash Bajaj, Ujjaini Dasgupta · 2024 · ACS Pharmacology & Translational Science
  5. Amyloid Precursor Protein (APP) Affects Global Protein Synthesis in Dividing Human Cells
    Anna Sobol, Paola Galluzzo, Shuang Liang, Brittany Rambo, Sylvia Skucha, Megan J. Weber, Sara Alani, Maurizio Bocchetta · 2014 · Journal of Cellular Physiology
  6. Left‐right asymmetry in the light of TOR: An update on what we know so far
    Teresa Casar Tena, Martin D. Burkhalter, Melanie Philipp · 2015 · Biology of the Cell
  7. Identification of a Non-Gatekeeper Hot Spot for Drug-Resistant Mutations in mTOR Kinase
    Wu Tzung-Ju, Xiaowen Wang, Yanjie Zhang, Linghua Meng, John E. Kerrigan, Stephen Kevin Burley, X.F. Steven Zheng · 2015 · Cell Reports
  8. Modulation of Cell Death in Age-Related Diseases
    Tuğsan Tezil, Hüveyda Başağa · 2014 · Current Pharmaceutical Design
  9. Relative Expression Levels Rather Than Specific Activity Plays the Major Role in DeterminingIn VivoAKT Isoform Substrate Specificity
    Rachel S. Lee, Colin M. House, Briony E. Cristiano, Ross D. Hannan, Richard B. Pearson, Katherine M. Hannan · 2011 · Enzyme Research
  10. Autophagy induction by tetrahydrobiopterin deficiency
    Sang Su Kwak, Jinkyu Suk, Ji Hye Choi, Seungkyung Yang, Jin Woo Kim, Seonghyang Sohn, Jae Hoon Chung, Yong Hee Hong, Dong Hwan Lee, Jeong Keun Ahn et al. · 2011 · Autophagy
  11. AKT-mediated phosphorylation of TSC2 controls stimulus- and tissue-specific mTORC1 signaling and organ growth
    Y. Cormerais, Samuel C. Lapp, Krystle C. Kalafut, Madi Y. Cissé, Jong Shin, Benjamin Stefadu, Jean Personnaz, Sandra Schrotter, Jessica Freed, Angelica D’Amore et al. · 2025 · Developmental Cell
  12. Phosphorylation of PRAS40‐Thr246 Involved in Renal Lipid Accumulation of Diabetes
    Jun Hao, Li Fan, Wei Xin Liu, Qingjuan Liu, Shuxia Liu, Hongbo Li, Huijun Duan · 2013 · Journal of Cellular Physiology
  13. Tuberin and PRAS40 are anti-apoptotic gatekeepers during early human amniotic fluid stem-cell differentiation
    Christiane Fuchs, Margit Rosner, Helmut Dolznig, Mario Mikula, Nina Kramer, Markus Hengstschläger · 2011 · Human Molecular Genetics
  14. The Role of IL-6 Released During Exercise to Insulin Sensitivity and Muscle Hypertrophy
    Vera Lúcia de Menezes Lima, Álvaro Nóbrega de Melo Madureira, João Ricardhis Saturnino de Oliveira · 2022 · Mini-Reviews in Medicinal Chemistry
  15. The “Road” to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review
    Radwa Hablase, Ioannis Kyrou, Harpal Singh Randeva, Emmanouíl Karteris, Jayanta Chatterjee · 2024 · Cancers
  16. Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity
    Janani Panneerselvam, Manish Shanker, Jiankang Jin, Cynthia D. Branch, Ranganayaki Muralidharan, Yan Daniel Zhao, Sunil Chada, Anupama Munshi, Rajagopal Ramesh · 2015 · Oncotarget
  17. Gβγ interacts with mTOR and promotes its activation
    Evelyn Robles‐Molina, Misael Neri Dionisio-Vicuña, María Luisa Guzmán-Hernández, Guadalupe Reyes‐Cruz, José Vázquez‐Prado · 2014 · Biochemical and Biophysical Research Communications
  18. Computational Modeling and Analysis of Insulin Induced Eukaryotic Translation Initiation
    Joshua P. Lequieu, Anirikh Chakrabarti, Satyaprakash Nayak, Jeffrey D. Varner · 2011 · PLoS Computational Biology
  19. Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells
    Chao Zhang, Lei Yang, Yadi Geng, Faliang An, Yuan‐Zheng Xia, Chao Guo, Jian‐Guang Luo, Luyong Zhang, Qinglong Guo, Ling‐Yi Kong · 2016 · Oncotarget
  20. Bisphenol-A and Nonylphenol Induce Apoptosis in Reproductive Tract Cancer Cell Lines by the Activation of ADAM17
    Paulina Urriola‐Muñoz, Raúl Lagos‐Cabré, Daniel Patiño-García, Juan G. Reyes, Ricardo D. Moreno · 2018 · International Journal of Molecular Sciences
  21. White Adipose Tissue Expansion in Multiple Symmetric Lipomatosis Is Associated with Upregulation of CK2, AKT and ERK1/2
    Marta Sanna, Christian Borgo, Chiara Compagnin, Francesca Favaretto, Vincenzo Vindigni, Mariangela Trento, Silvia Bettini, Alessandra Comin, Anna Belligoli, Massimo Rugge et al. · 2020 · International Journal of Molecular Sciences
  22. Methylene-bridge tryptophan fatty acylation regulates PI3K-AKT signaling and glucose uptake
    Songhua Hu, Xiadi He, Ji Nie, Jun‐Li Hou, Jiang Wu, Xiaoyan Liu, Yun Wei, Huiru Tang, Wen-Xing Sun, Shu-Xian Zhou et al. · 2022 · Cell Reports
  23. Oocyte Quiescence: From Formation to Awakening
    Jeongho Kim, Young‐Jai You · 2022 · Endocrinology
  24. mTOR Signaling Pathway in Bone Diseases Associated with Hyperglycemia
    Shuangcheng Wang, Jiale Wang, Shuangwen Wang, Ran Tao, Jianru Yi, Miao Chen, Zhihe Zhao · 2023 · International Journal of Molecular Sciences
  25. Using Drosophila melanogaster to Dissect the Roles of the mTOR Signaling Pathway in Cell Growth
    Anna Frappaolo, Maria Grazia Giansanti · 2023 · Cells
  26. Glucocorticoids attenuate the central sympathoexcitatory actions of insulin
    Jennifer L. Steiner, Megan Elyse Bardgett, Lawrence Wolfgang, Charles H. Lang, Sean D. Stocker · 2014 · Journal of Neurophysiology
  27. Hydrophobic motif site-phosphorylated protein kinase CβII between mTORC2 and Akt regulates high glucose-induced mesangial cell hypertrophy
    Falguni Das, Nandini Ghosh‐Choudhury, Meenalakshmi M. Mariappan, Balakuntalam S. Kasinath, Goutam Ghosh Choudhury · 2016 · American Journal of Physiology-Cell Physiology
  28. Caspase-mediated cleavage of raptor participates in the inactivation of mTORC1 during cell death
    R Martin, Chantal Desponds, Remzi Onur Eren, Manfredo Quadroni, Margot Thome, Nicolas J. Fasel · 2016 · Cell Death Discovery
  29. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway
    Aleksandar Pantovic, Mihajlo Bošnjak, Katarina M. Arsikin, Milica Kosić, Miloš Mandić, Biljana Z. Ristic, Jelena Tasić, Danica Grujičić, Aleksandra Isaković, Nikola Micic et al. · 2016 · The International Journal of Biochemistry & Cell Biology
  30. Recombinant Human Erythropoietin Protects Against Hippocampal Damage in Developing Rats with Seizures by Modulating Autophagy via the S6 Protein in a Time-Dependent Manner
    Qinrui Li, Ying Han, Junbao Du, Hongfang Jin, Jing Zhang, Manman Niu, Jiong Qin · 2017 · Neurochemical Research
  31. Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk
    Mohsen Saravani, Hossein Shahraki-Ghadimi, Rostam Maruei‐Milan, Mehrnaz Mehrabani, Solmaz Mirzamohammadi, Mohammad Hadi Nematollahi · 2020 · Molecular Biology Reports
  32. Gene expression and regulatory factors of the mechanistic target of rapamycin (mTOR) complex 1 predict mammalian longevity
    Natàlia Mota‐Martorell, Mariona Jové, Irene Pradas, Rebeca Berdún, I. Prieto Sánchez, Alba Naudí, Eloi Garí, Gustavo Barja, Reinald Pamplona · 2020 · GeroScience
  33. Translation elongation factor 2 depletion by siRNA in mouse liver leads to mTOR-independent translational upregulation of ribosomal protein genes
    Maxim V. Gerashchenko, Mikhail V. Nesterchuk, Elena M. Smekalova, João A. Paulo, Piotr S. Kowalski, Kseniya A. Akulich, Roman L. Bogorad, Sergey E. Dmitriev, Steven P. Gygi, Timofei S. Zatsepin et al. · 2020 · Scientific Reports
  34. Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review
    Aleksandra Derwich-Rudowicz, Monika Sykutera, Barbara Bromińska, Mirosław Andrusiewicz, Marek Ruchała, Nadia Sawicka‐Gutaj · 2023 · Cancers
  35. Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
    Satohiro Masuda, Florian Lemaitre, Markus Johannes Barten, Stein Bergan, Maria Shipkova, Teun van Gelder, Sander Vinks, Eberhard Wieland, Kirsten Bornemann-Kolatzki, Mercè Brunet et al. · 2024 · Therapeutic Drug Monitoring
  36. Kinetic Modeling and Analysis of the Akt/Mechanistic Target of Rapamycin Complex 1 (mTORC1) Signaling Axis Reveals Cooperative, Feedforward Regulation
    Anisur Rahman, Jason M. Haugh · 2017 · Journal of Biological Chemistry
  37. PRAS40 Phosphorylation Correlates with Insulin-Like Growth Factor-1 Receptor-Induced Resistance to Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells
    Michael I. Dougherty, Christine E. Lehman, Adam Spencer, Rolando E. Mendez, Abel P. David, Linnea E. Taniguchi, Julie Wulfkuhle, Emanuel F. Petricoin, Daniel G. Gioeli, Mark J. Jameson · 2020 · Molecular Cancer Research
  38. The role of the mTOR pathway in models of drug-induced reward and the behavioural constituents of addiction
    Marcos Ucha, David Roura‐Martínez, Emilio Ambrosio, Alejandro Higuera‐Matas · 2020 · Journal of Psychopharmacology
  39. Cancer causes dysfunctional insulin signaling and glucose transport in a muscle‐type‐specific manner
    Steffen Henning Raun, Jonas R. Knudsen, Xiuqing Han, Thomas E. Jensen, Lykke Sylow · 2022 · The FASEB Journal
  40. Knockdown of PRAS40 inhibits insulin action via proteasome-mediated degradation of IRS1 in primary human skeletal muscle cells
    Claudia Wiza, Daniella Herzfeld de Wiza, Emmani B. M. Nascimento, Stefan Lehr, Hadi Al‐Hasani, D. Margriet Ouwens · 2013 · Diabetologia
  41. Eukaryotic initiation factor 4E is a novel effector of mTORC1 signaling pathway in cross talk with Mnk1
    Asiya Batool, Sheikh Tahir Majeed, Sabreena Aashaq, Rabiya Majeed, Nadiem Nazir Bhat, Khurshid Iqbal Andrabi · 2019 · Molecular and Cellular Biochemistry
  42. Recent advances in amino acid sensing and new challenges for protein nutrition in aquaculture
    Cheng-Dong Liu, Xuan Wang, Hui-Hui Zhou, K. Mai, G. He · 2019 · Marine Life Science & Technology
  43. Enzyme-treated soy protein supplementation in low protein diet enhanced immune function of immune organs in on-growing grass carp
    Yan Song, Liang‐Chao Yan, Wei-Wei Xiao, Lin Feng, Wei‐Dan Jiang, Pei Wu, Yang Liu, Sheng‐Yao Kuang, Ling Yin Tang, Xiao‐Qiu Zhou · 2020 · Fish & Shellfish Immunology
  44. Medical Aspects of mTOR Inhibition in Kidney Transplantation
    Elena Cuadrado‐Payán, Fritz Diekmann, David Cucchiari · 2022 · International Journal of Molecular Sciences
  45. Drosophila melanogaster diabetes models and its usage in the research of anti-diabetes management with traditional Chinese medicines
    Yaodong Miao, Rui Chen, Xiaolu Wang, Jie Zhang, Weina Tang, Zeyu Zhang, Yaoyuan Liu, Qiang Xu · 2022 · Frontiers in Medicine
  46. Role of mechanistic target of rapamycin in autophagy and alcohol-associated liver disease
    Xiaojuan Chao, Sha Neisha Williams, Wen‐Xing Ding · 2022 · American Journal of Physiology-Cell Physiology
  47. Roles of Medicinal Plants and Constituents in Gynecological Cancer Therapy: Current Literature and Future Directions
    Esra Küpeli Akkol, Fatma Tuğçe Gürağaç Dereli, Eduardo Sobarzo‐Sánchez, Haroon Khan · 2020 · Current Topics in Medicinal Chemistry
  48. Aescin Protects Neuron from Ischemia-Reperfusion Injury via Regulating the PRAS40/mTOR Signaling Pathway
    Xinjie Gao, Heng Yang, Jiabin Su, Weiping Xiao, Wei Ni, Yuxiang Gu · 2020 · Oxidative Medicine and Cellular Longevity
  49. Development of a Whole Organism Platform for Phenotype-Based Analysis of IGF1R-PI3K-Akt-Tor Action
    Chengdong Liu, Wei Dai, Yan Bai, Changfeng Chi, Yi Xin, Gen He, Kangsen Mai, Cunming Duan · 2017 · Scientific Reports
  50. Unlocking longevity through the comparative biology of aging
    Cheyenne Rechsteiner, Francesco Morandini, Sei Joong Kim, Andrei Seluanov, Vera A. Gorbunova · 2025 · Nature Aging
  51. Modulatory effects of curcumin on Singapore grouper iridovirus infection-associated apoptosis and autophagy in vitro
    Yuexuan Wang, Suifeng Xu, Chengzong Han, Youhua Huang, Jingguang Wei, Shina Wei, Qiwei Qin · 2022 · Fish & Shellfish Immunology
  52. dRAGging Amino Acid-mTORC1 Signaling by SH3BP4
    Young Mi Kim, Do‐Hyung Kim · 2012 · Molecules and Cells
  53. PRAS40 deregulates apoptosis in Ewing sarcoma family tumors by enhancing the insulin receptor/Akt and mTOR signaling pathways.
    Dan Lv, Jinye Liu, Lianying Guo, Dawei Wu, Ken Matsumoto, Lin Huang · 2016 · PubMed Central
  54. MDM4 actively restrains cytoplasmic mTORC1 by sensing nutrient availability
    Francesca Mancini, Emanuela Teveroni, Giusy Di Conza, Valentina Monteleone, Ivan Arisi, Marsha Pellegrino, Marianna Buttarelli, Luisa Pieroni, Mara D’Onofrio, Andrea Urbani et al. · 2017 · Molecular Cancer
  55. PRAS40 promotes NF-κB transcriptional activity through association with p65
    Gangcai Zhu, Qi Qi, Jonathan J. Havel, Z Li, Yanhua Du, X Zhang, Haian Fu · 2017 · Oncogenesis
  56. Experimental Approaches in Delineating mTOR Signaling
    Jiayi Qian, Siyuan Su, Pengda Liu · 2020 · Genes
  57. Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace
    Maren Heimhalt, Alex Berndt, Jane L. Wagstaff, Madhanagopal Anandapadamanaban, Olga Perišić, Sarah Maslen, Stephen H. McLaughlin, Conny Wing-Heng Yu, Glenn Robert Masson, Andreas Boland et al. · 2021 · eLife
  58. High-throughput Exploration of the Network Dependent on AKT1 in Mouse Ovarian Granulosa Cells
    Maëva Elzaïat, Laetitia Herman, Bérangère Legois, Thibaut Léger, Anne‐Laure Todeschini, Reiner A. Veitia · 2019 · Molecular & Cellular Proteomics
  59. Insulin-induced mTOR signaling and gluconeogenesis in renal proximal tubules: A mini-review of current evidence and therapeutic potential
    Motonobu Nakamura, Nobuhiko Satoh, Shoko Horita, Masaomi Nangaku · 2022 · Frontiers in Pharmacology
  60. GOLPH3 protein controls organ growth by interacting with TOR signaling proteins in Drosophila
    Anna Frappaolo, Angela Karimpour-Ghahnavieh, Giuliana Cesare, Stefano Sechi, Roberta Fraschini, Thomas Vaccari, Maria Grazia Giansanti · 2022 · Cell Death and Disease
  61. Tat-PRAS40 prevent hippocampal HT-22 cell death and oxidative stress induced animal brain ischemic insults
    Min Jea Shin, Dae Won Kim, Hyo Sang Jo, Su Bin Cho, Jung Hwan Park, Chi Hern Lee, Eun Ji Yeo, Yeon Joo Choi, Ji An Kim, Jung Soon Hwang et al. · 2016 · Free Radical Biology and Medicine
  62. microRNA-181a downregulates deptor for TGFβ-induced glomerular mesangial cell hypertrophy and matrix protein expression
    Soumya Maity, Amit Bera, Nandini Ghosh‐Choudhury, Falguni Das, Balakuntalam S. Kasinath, Goutam Ghosh Choudhury · 2018 · Experimental Cell Research
  63. mTOR/PRAS40 interaction: Hypertrophy or proliferation
    Mirko Völkers, Mark Alan Sussman · 2013 · Cell Cycle
  64. Tyrosine phosphorylation of DEPTOR functions as a molecular switch to activate mTOR signaling
    Laurence M. Gagné, Nadine Morin, Noémie Lavoie, Nicolas Bisson, Jean-Philippe Lambert, Frédérick A. Mallette, Marc-Étienne Huot · 2021 · Journal of Biological Chemistry
  65. mTOR signaling regulates Zika virus replication bidirectionally through autophagy and protein translation
    Bin Liu, Yahui Zhang, Hao Ren, Qiu-Feng Yao, Jianbo Ba, Jie Luan, Ping Zhao, Zhao-ling Qin, Zhongtian Qi · 2022 · Journal of Medical Virology
  66. Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives
    Antonios N. Gargalionis, Kostas A. Papavassiliou, Athanasios G. Papavassiliou · 2023 · Cells
  67. Mechanisms mediating the effects of alcohol and HIV anti-retroviral agents on mTORC1, mTORC2 and protein synthesis in myocytes
    Ly Q. Hong‐Brown · 2012 · World Journal of Biological Chemistry
  68. Autophagy response: manipulating the mTOR-controlled machinery by amino acids and pathogens
    Claudio Marcelo Fader, Milton Osmar Aguilera, María Isabel Colombo · 2014 · Amino Acids
  69. Effects of metformin on fertilisation of bovine oocytes and early embryo development: possible involvement of AMPK3-mediated TSC2 activation
    Olympia Pikiou, Anna Vasilaki, George Leondaritis, Nikos C. Vamvakopoulos, Ioannis E. Messinis · 2013 · Zygote
  70. Overcoming resistance to rapalogs in gliomas by combinatory therapies
    Michal Grzmil, Brian A. Hemmings · 2013 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  71. Molecular challenges of neuroendocrine tumors (Review)
    Parthik Patel, Karina A. Galoian · 2017 · Oncology Letters
  72. Pathological Consequences of Hepatic mTORC1 Dysregulation
    C. Cho, A. H. Kowalsky, Jun-Hee Lee · 2020 · Genes
  73. Translational implications of endothelial cell dysfunction in association with chronic allograft rejection
    Sarah Bruneau, Johannes Wedel, Fádi Fakhouri, Hironao Nakayama, Leo Boneschansker, Daniel Irimia, Kevin P. Daly, David Michael Briscoe · 2015 · Pediatric Nephrology
  74. Control of cell growth: Rag GTPases in activation of TORC1
    Huirong Yang, Rui Gong, Yanhui Xu · 2012 · Cellular and Molecular Life Sciences
  75. Down-regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Enhances Gensenoside Rh2 Pharmacological Action on Leukemia KG1α Cells
    Zhimei You, Liang Zhao, Jing Xia, Qiang Wei, Yumin Liu, Xiao-Yan Liu, Dilong Chen, Jing Li · 2014 · Asian Pacific Journal of Cancer Prevention
  76. Heat shock protein 70 promotes coxsackievirus B3 translation initiation and elongation via Akt-mTORC1 pathway depending on activation of p70S6K and Cdc2
    Fengping Wang, Ye Qiu, Huifang M. Zhang, Paul Hanson, Xin Ye, Guangze Zhao, Ronald Xie, Lei Tong, Decheng Yang · 2017 · Cellular Microbiology
  77. Oncogenic kinases and perturbations in protein synthesis machinery and energetics in neoplasia
    Oro Uchenunu, Michaël Pollak, Ivan Topisirović, Laura Hulea · 2018 · Journal of Molecular Endocrinology
  78. Fission yeast TOR complex 1 phosphorylates Psk1 through an evolutionarily conserved interaction mediated by the TOS motif
    Yuichi Morozumi, Ai Hishinuma, Suguru Furusawa, Fajar Sofyantoro, Hisashi Tatebe, Kazuhiro Shiozaki · 2021 · Journal of Cell Science
  79. Oncolytic Avian Reovirus p17-Modulated Inhibition of mTORC1 by Enhancement of Endogenous mTORC1 Inhibitors Binding to mTORC1 To Disrupt Its Assembly and Accumulation on Lysosomes
    Jyun‐Yi Li, Wei‐Ru Huang, Tsai‐Ling Liao, Brent L. Nielsen, Hung‐Jen Liu · 2022 · Journal of Virology
  80. Mammalian Target of Rapamycin Complex I (mTORC1) Activity in Ras Homologue Enriched in Brain (Rheb)-Deficient Mouse Embryonic Fibroblasts
    Marlous J. Groenewoud, Susan M. I. Goorden, Jorien Kassies, Wendy Pellis-van Berkel, Richard F. Lamb, Ype Elgersma, Fried J. T. Zwartkruis · 2013 · PLoS ONE
  81. Tracking the Activity of mTORC1 in Living Cells Using Genetically Encoded FRET‐based Biosensor TORCAR
    Xin Zhou, Simin Li, Jin Zhang · 2016 · Current Protocols in Chemical Biology
  82. Mechanism and Physiological Significance of Growth Factor-Related Autophagy
    Terytty Yang Li, Sheng‐Cai Lin, Sheng‐Cai Lin · 2013 · Physiology
  83. Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration
    Jordi Creus‐Muncunill, Laura Rué, Rafael Alcalá‐Vida, Raquel Badillos-Rodríguez, Joan Romaní-Aumedes, Sònia Marco, Jordi Alberch, Isabel Pérez‐Otaño, Cristina Malagelada, Esther Pérez‐Navarro · 2018 · Molecular Neurobiology
  84. Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue
    Ling Yeong Chia, Bronwyn A. Evans, Saori Mukaida, Tore Bengtsson, Dana S. Hutchinson, Masaaki Sato · 2019 · British Journal of Pharmacology
  85. Triglycerides, Glucose Metabolism, and Type 2 Diabetes
    Yutang Wang · 2025 · International Journal of Molecular Sciences
  86. mTOR
    Aaron Mark Robitaille, Michael N. Hall · 2008 · AfCS-Nature Molecule Pages
  87. Effects of Acute Muscle Contraction on the Key Molecules in Insulin and Akt Signaling in Skeletal Muscle in Health and in Insulin Resistant States
    Gagandeep Mann, Michael Charles Riddell, Olasunkanmi A. J. Adegoke · 2022 · Diabetology
  88. Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14
    Lucía Sanjurjo, Esmeralda Castelblanco, Josep Julve, Núria Villalmanzo, Érica Téllez, Anna Ramírez‐Morros, Núria Alonso, Dı́dac Mauricio, Maria‐Rosa Sarrias · 2023 · Antioxidants
  89. Post-translational regulation of the mTORC1 pathway: A switch that regulates metabolism-related gene expression.
    Yitao Wang, T. Engel, Xinchen Teng · 2024 · Biochimica et Biophysica Acta. Gene Regulatory Mechanisms
  90. Fine-tuning AMPK in physiology and disease using point-mutant mouse models
    Naghmana Ashraf, Jeanine L. Van Nostrand · 2024 · Disease Models & Mechanisms
  91. Ischemia-Induced Changes of PRAS40 and p-PRAS40 Immunoreactivities in the Gerbil Hippocampal CA1 Region After Transient Cerebral Ischemia
    Joon Ha Park, Bich Na Shin, Ji Hyeon Ahn, Jeong-Hwi Cho, In Hye Kim, Dae Won Kim, Moo‐Ho Won, Seongkweon Hong, Jun Hwi Cho, Choong Hyun Lee · 2015 · Cellular and Molecular Neurobiology
  92. mTORC1 silencing during intestinal epithelial Caco-2 cell differentiation is mediated by the activation of the AMPK/TSC2 pathway
    Harleen Kaur, Régis F. Moreau · 2021 · Biochemical and Biophysical Research Communications
  93. Transduced Tat-PRAS40 prevents dopaminergic neuronal cell death through ROS inhibition and interaction with 14-3-3σ protein
    Won Sik Eum, Dae Won Kim, Eun Ji Yeo, Hyeon Ji Yeo, Yeon Joo Choi, HYUN JU CHA, Jinseu Park, Kyu Hyung Han, Duk‐Soo Kim, Yeon Hee Yu et al. · 2021 · Free Radical Biology and Medicine
  94. Role of mTOR Signaling for Tubular Function and Disease
    Florian Grahammer, Tobias Bruno Huber, Ferruh Artunç · 2021 · Physiology
  95. Research Resource: Identification of Novel Growth Hormone-Regulated Phosphorylation Sites by Quantitative Phosphoproteomics
    Bridgette N. Ray, Hye Kyong Kweon, Lawrence S. Argetsinger, Diane C. Fingar, Philip Andrews, Christin Carter‐Su · 2012 · Molecular Endocrinology
  96. Soluble Factors from Human Olfactory Neural Stem/Progenitor Cells Influence the Fate Decisions of Hippocampal Neural Precursor Cells
    Laura Gomez‐Virgilio, Gerardo Bernabé Ramírez-Rodríguez, Carmen Sánchez‐Torres, Leonardo Ortíz‐López, Marco Antonio Meraz‐Ríos · 2018 · Molecular Neurobiology
  97. TIFA promotes colorectal cancer cell proliferation in an RSK ‐ and PRAS40 ‐dependent manner
    Wenzhi Shen, Wenfei Du, Yanping Li, Yongming Huang, Xinyu Jiang, Chenglong Yang, Jiaping Tang, Huan Liu, Na Luo, Xiaoyuan Zhang et al. · 2022 · Cancer Science
  98. Signal integration in the (m)TORC1 growth pathway
    Ramlaul, Kailash, Aylett, Christopher H. S. · 2018 · Frontiers in Biology
  99. Signaling Pathways Leading to mTOR Activation Downstream Cytokine Receptors in Lymphocytes in Health and Disease
    Lucie Fallone, Thierry Walzer, Antoine Marçais · 2023 · International Journal of Molecular Sciences
  100. Glucose Metabolic Abnormality: A Crosstalk between Depression and Alzheimer’s Disease
    Shaobin Yang, Yanhong Li, Qi Tang, Yimeng Zhang, Tingji Shao · 2024 · Current Neuropharmacology